GLOBAL GENETIC TESTING MARKET FORECAST 2018-2026
- January 2018 •
- 125 pages •
- Report ID: 4671066
Rise in the prevalence of genetic disorders is a key driver for the global genetic testing market. The market, which stood at $ 5054 million in 2017, is expected to rise at 9.97% CAGR over the forecast period of 2018- 2026 and is predicted to generate $11856 million by its end.
Market segmentation is done on the basis of applications and testing types. Global genetic testing market by applications include areas like prenatal, cancer, pharmacogenomics and predispositions. Genetic testing market by type is segmented into diagnostic testing, predictive and presymptomatic testing, preimplantation genetic diagnosis and newborn and prenatal testing.
Regional segmentation of the market is done into Asia, Europe, North America and rest of world. The Asia-Pacific market is predicted to grow with the fastest CAGR while the North American market is expected to capture the largest revenue share by the end of the forecast period. The APC market is driven by growing research in molecular biology applications, infectious disease testing and cancer risk studies, while the North American market is driven by the presence of key market players.
Cepheid, Genentech Inc, Daan Diagnostics Ltd, Genomictree Inc, Illumina, Inc, HTG Molecular Diagnostics, Inc, Integragen S.A, Luminex Corporation, Laboratory Corporation Of America Holdings, Molecularmd Corp, Oxford Biodynamics Limited, Natera Inc, Pacific Biosciences Of California Inc, Qiagen N.V, Perkinelmer Inc, and Roche Diagnostics Corporation are some of the important players in this market